Vanguard Fiduciary Trust
FOLD

Vanguard Fiduciary Trust’s Amicus Therapeutics FOLD Stock Holding History

Vanguard Fiduciary Trust’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,139,129
Closed -$30.9M – 4105
2026
Q1 		$30.9M Buy
+2,139,129
New +$30.7M 0.01% 1059

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Vanguard Fiduciary Trust's FOLD Position: Q2 2026 in Review

Vanguard Fiduciary Trust sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 2,139,129 shares — an estimated $30.9M sold.

Vanguard Fiduciary Trust first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $30.9M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Vanguard Fiduciary Trust reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Vanguard Fiduciary Trust sold 2,139,129 Amicus Therapeutics shares in Q2 2026, an estimated $30.9M.
  • Vanguard Fiduciary Trust first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
  • Vanguard Fiduciary Trust's Amicus Therapeutics position peaked at $30.9M in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.